Rogue Funds Shows Confidence in Biotricity (BTCY) Amidst Stock Decline

Rogue Funds released its first quarter 2025 investor letter, revealing a 12.4% depreciation in the fund net of fees. Anticipating significant volatility, the firm warns of both declines and rises in total returns. Check the fund’s top 5 holdings for insights on their best picks for 2025.

Biotricity, Inc. (OTC:BTCY) was highlighted in Rogue Funds’ investor letter, showcasing a -19.98% one-month return and a 45.13% drop in shares over 52 weeks. As of July 3, 2025, the stock closed at $0.42 per share with a market cap of $10.465 million.

In the same letter, Rogue Funds discusses their stake in Biotricity, Inc. (OTC:BTCY), emphasizing the company’s three-lead heart monitor and AI technology for heart issue predictability. With a focus on SAAS conversion, the company has seen increased revenue and gross margin expansion expected to continue.

Read more at Yahoo Finance: Rogue Funds’ New Holding: Biotricity (BTCY)